EP0124317B1
(en)
*
|
1983-04-27 |
1990-04-11 |
Ici Americas Inc. |
Proline derivatives
|
FR2663336B1
(fr)
|
1990-06-18 |
1992-09-04 |
Adir |
Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
FR2713225B1
(fr)
|
1993-12-02 |
1996-03-01 |
Sanofi Sa |
N-pipéridino-3-pyrazolecarboxamide substitué.
|
US5631365A
(en)
*
|
1993-09-21 |
1997-05-20 |
Schering Corporation |
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
|
US5656624A
(en)
*
|
1994-12-21 |
1997-08-12 |
Schering Corporation |
4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
|
HU226822B1
(en)
|
1995-10-31 |
2009-11-30 |
Schering Corp |
Hypocholesterolemic sugar-substituted 2-azetidinones, and pharmaceutical compns. contg. them
|
BR9707003A
(pt)
|
1996-01-17 |
1999-07-20 |
Novo Nordisk As |
Composto processos para preparar o mesmo para tratamento ou de prevenção de doenças do sistema endócrino e para a manufatura de medicamento coposção farmacêutica e utilização de um composto
|
US6225310B1
(en)
*
|
1996-01-17 |
2001-05-01 |
Novo Nordisk A/S |
Fused 1,2,4-thiadiazine derivatives, their preparation and use
|
US5739321A
(en)
|
1996-05-31 |
1998-04-14 |
Schering Corporation |
3-hydroxy γ-lactone based enantionselective synthesis of azetidinones
|
CA2468374C
(en)
|
1996-08-30 |
2010-12-21 |
Novo-Nordisk A/S |
Glp-1 derivatives
|
US6268343B1
(en)
*
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US5756470A
(en)
*
|
1996-10-29 |
1998-05-26 |
Schering Corporation |
Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
|
CN1190434C
(zh)
|
1996-12-31 |
2005-02-23 |
雷迪实验室有限公司 |
新的杂环化合物、其制备方法和含有它们的药物组合物及其在治疗糖尿病和相关疾病中的应用
|
DE19726167B4
(de)
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
|
BR9810592A
(pt)
|
1997-07-16 |
2000-09-12 |
Novo Nordisk As |
Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto
|
CO4970713A1
(es)
|
1997-09-19 |
2000-11-07 |
Sanofi Synthelabo |
Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
|
EE200000504A
(et)
*
|
1998-03-12 |
2002-02-15 |
Teijin Limited |
Bensofurüül-a-pürooni derivaadid, farmatseutilinekompositsioon, lipiidide ainevahetuse kiirendaja,triglütseriidi biosünteesi inhibiitor, vere triglütseriiditaset alandav toimeaine, vere HDL taset tõstev toimeaine, arterioskleroosi profülaktiline to
|
US6221897B1
(en)
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
DE19845405C2
(de)
|
1998-10-02 |
2000-07-13 |
Aventis Pharma Gmbh |
Arylsubstituierte Propanolaminderivate und deren Verwendung
|
CZ295044B6
(cs)
|
1998-12-07 |
2005-05-18 |
Societe De Conseils De Recherches Et D'application |
Analogy GLP-1, mající kyselinu aminoizomáselnou na pozicích 8 a 35, jejich použití a farmaceutické prostředky je obsahující
|
GB9900416D0
(en)
|
1999-01-08 |
1999-02-24 |
Alizyme Therapeutics Ltd |
Inhibitors
|
DE19916108C1
(de)
|
1999-04-09 |
2001-01-11 |
Aventis Pharma Gmbh |
Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
AU4343500A
(en)
|
1999-04-16 |
2000-11-02 |
Schering Corporation |
Use of azetidinone compounds
|
ES2287016T3
(es)
|
1999-04-28 |
2007-12-16 |
Sanofi-Aventis Deutschland Gmbh |
Derivados de diaril-acido como ligandos del receptor ppar.
|
SK15522001A3
(sk)
|
1999-04-28 |
2002-06-04 |
Aventis Pharma Deutschland Gmbh |
Deriváty kyselín s tromi arylovými zvyškami ako ligandy receptorov PPAR a farmaceutické kompozície, ktoré ich obsahujú
|
GB9911863D0
(en)
|
1999-05-21 |
1999-07-21 |
Knoll Ag |
Therapeutic agents
|
US6399640B1
(en)
|
1999-06-18 |
2002-06-04 |
Merck & Co., Inc. |
Arylthiazolidinedione and aryloxazolidinedione derivatives
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
JP2003506365A
(ja)
|
1999-07-29 |
2003-02-18 |
イーライ・リリー・アンド・カンパニー |
ベンゾフリルピペラジンおよびベンゾフリルホモピペラジン:セロトニンアゴニスト
|
PL353367A1
(en)
|
1999-09-01 |
2003-11-17 |
Aventis Pharma Deutschland Gmbh |
Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
|
PE20011010A1
(es)
|
1999-12-02 |
2001-10-18 |
Glaxo Group Ltd |
Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
|
JP2003523396A
(ja)
|
2000-02-25 |
2003-08-05 |
ノボ ノルディスク アクティーゼルスカブ |
ベータ細胞変性の抑制
|
CN1430603A
(zh)
|
2000-04-28 |
2003-07-16 |
旭化成株式会社 |
新型双环化合物
|
DE60115227T2
(de)
|
2000-05-11 |
2006-08-24 |
Bristol-Myers Squibb Co. |
Tetrahydroisochinolin-analoga als wachstumshormon-sekretagoga
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
DE60128475T2
(de)
*
|
2000-07-25 |
2008-02-07 |
Merck & Co., Inc. |
N-substituierte indole mit anwendung in der behandlung von diabetes
|
HUP0004741A2
(hu)
|
2000-11-28 |
2002-12-28 |
Sanofi-Synthelabo |
Kémiai eljárás tiazolszármazékok előállítására és új intermedier
|
IL156548A0
(en)
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
ATE349425T1
(de)
|
2000-12-21 |
2007-01-15 |
Sanofi Aventis Deutschland |
Neue diphenzylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung zur behandlung von lipidstoffwechselstörungen
|
IL156552A0
(en)
*
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
TWI291957B
(en)
|
2001-02-23 |
2008-01-01 |
Kotobuki Pharmaceutical Co Ltd |
Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
|
GB0113233D0
(en)
|
2001-05-31 |
2001-07-25 |
Glaxo Group Ltd |
Chemical compounds
|
DE10139416A1
(de)
|
2001-08-17 |
2003-03-06 |
Aventis Pharma Gmbh |
Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US6884812B2
(en)
*
|
2001-08-31 |
2005-04-26 |
Aventis Pharma Deutschland Gmbh |
Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
|
UA76773C2
(uk)
*
|
2001-08-31 |
2006-09-15 |
Санофі-Авентіс Дойчланд Гмбх |
Діарилциклоалкільні похідні, спосіб їх одержання і їх застосування як ppar-активаторів
|
IL164249A0
(en)
|
2002-04-11 |
2005-12-18 |
Aventis Pharma Gmbh |
Acyl-3-carboxphenylurea derivatives, processes forpreparing them and their use
|
JPWO2003097064A1
(ja)
|
2002-05-17 |
2005-09-15 |
協和醗酵工業株式会社 |
糖尿病治療剤
|
DE10227506A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE10227508A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Säuregruppen-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
US7671047B2
(en)
*
|
2002-06-19 |
2010-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
|
DE10227507A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Kationisch substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
US7176194B2
(en)
*
|
2002-06-19 |
2007-02-13 |
Sanofi-Aventis Deutschland Gmbh |
Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
|
US7176193B2
(en)
*
|
2002-06-19 |
2007-02-13 |
Sanofi-Aventis Deutschland Gmbh |
Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
|
GB0215579D0
(en)
*
|
2002-07-05 |
2002-08-14 |
Astrazeneca Ab |
Chemical compounds
|
DE50312261D1
(de)
|
2002-07-12 |
2010-02-04 |
Sanofi Aventis Deutschland |
Heterozyklisch substituierte benzoylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
DE10314610A1
(de)
|
2003-04-01 |
2004-11-04 |
Aventis Pharma Deutschland Gmbh |
Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung
|
CN100472485C
(zh)
|
2003-04-25 |
2009-03-25 |
松下电器产业株式会社 |
服务器及服务器的处理方法
|
JP2005015434A
(ja)
|
2003-06-27 |
2005-01-20 |
Kotobuki Seiyaku Kk |
血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
|
CA2531836A1
(en)
|
2003-07-09 |
2005-01-20 |
Forbes Medi-Tech Inc. |
Novel compounds and compositions comprising sterols and/or stanols and cholesterol biosynthesis inhibitors and use thereof in treating or preventing a variety of diseases and conditions.
|
WO2005005477A2
(en)
|
2003-07-11 |
2005-01-20 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
US20070072812A1
(en)
|
2003-08-25 |
2007-03-29 |
Microbia, Inc. |
Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
|
US20070161577A1
(en)
|
2003-08-28 |
2007-07-12 |
Martinez Eduardo J |
Tethered dimers and trimers of 1,4-diphenylazetidin-2-ones
|
TW200526254A
(en)
|
2003-09-19 |
2005-08-16 |
Novo Nordisk As |
Novel GLP-1 derivatives
|
EP1522541A1
(en)
|
2003-10-07 |
2005-04-13 |
Lipideon Biotechnology AG |
Novel hypocholesterolemic compounds
|
US20070135357A1
(en)
|
2003-10-30 |
2007-06-14 |
Sings Heather L |
Anti-hypercholesterolemic compounds
|
WO2005042692A2
(en)
|
2003-10-31 |
2005-05-12 |
Forbes Medi-Tech Inc. |
A method of inhibiting the expression of genes which mediate cellular cholesterol influx in animal cells and inhibiting the production of proteins resulting from the expression of such genes using cholesterol absorption inhibitors
|
ATE369335T1
(de)
|
2003-11-10 |
2007-08-15 |
Microbia Inc |
4-biarylyl-1-phenylazetidin-2-one
|
US7871998B2
(en)
|
2003-12-23 |
2011-01-18 |
Astrazeneca Ab |
Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity
|
AU2004308332B2
(en)
|
2003-12-23 |
2008-04-10 |
Merck Sharp & Dohme Corp. |
Anti-hypercholesterolemic compounds
|
GB0329778D0
(en)
|
2003-12-23 |
2004-01-28 |
Astrazeneca Ab |
Chemical compounds
|
CN1901917A
(zh)
|
2004-01-06 |
2007-01-24 |
詹森药业有限公司 |
作为糖原磷酸化酶抑制剂用于治疗糖尿病和肥胖症的(3-氧代-3,4-二氢-喹喔啉-2-基-氨基)-苯甲酰胺衍生物和相关化合物
|
DE102004006325A1
(de)
|
2004-02-10 |
2005-08-25 |
Bayer Healthcare Ag |
Tetrahydrobenzo[d]azepin-2-on-Derivate und ihre Verwendung
|
WO2005085226A1
(en)
|
2004-03-10 |
2005-09-15 |
Janssen Pharmaceutica N.V. |
Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
|
EP1736467A4
(en)
|
2004-04-06 |
2009-07-01 |
Dainippon Sumitomo Pharma Co |
NEW SULFONIC ACID AMID DERIVATIVE
|
US20070202179A1
(en)
|
2004-04-09 |
2007-08-30 |
FAULKNER Patrick |
Low Dose Pharmaceutical Products
|
DE102004025072A1
(de)
*
|
2004-05-21 |
2005-12-15 |
Sanofi-Aventis Deutschland Gmbh |
Verfahren zur Herstellung von Diphenyl-azetidinon-Derivaten
|
FR2871463B1
(fr)
|
2004-06-11 |
2006-09-22 |
Merck Sante Soc Par Actions Si |
Derives a structure aroyl-o-piperidine, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en therapeutique
|
EA200700119A1
(ru)
|
2004-06-24 |
2007-10-26 |
Эли Лилли Энд Компани |
Соединения и способы лечения дислипидемии
|
WO2006017257A2
(en)
|
2004-07-12 |
2006-02-16 |
Phenomix Corporation |
Azetidinone derivatives
|
FR2873368B1
(fr)
|
2004-07-26 |
2008-01-04 |
Merck Sante Soc Par Actions Si |
Derives de guanidine et leurs utilisations en therapeutique
|
FR2873694B1
(fr)
|
2004-07-27 |
2006-12-08 |
Merck Sante Soc Par Actions Si |
Nouveaux aza-indoles inhibiteurs de la mtp et apob
|
EP1794159B1
(en)
|
2004-09-11 |
2012-08-01 |
Sanofi-Aventis Deutschland GmbH |
7-azaindoles and their use as ppar agonists
|
US7893017B2
(en)
|
2004-10-07 |
2011-02-22 |
Novo Nordisk A/S |
Protracted GLP-1 compounds
|
EP2330126B1
(en)
|
2004-10-07 |
2015-12-23 |
Novo Nordisk A/S |
Protracted exendin-4 compounds
|
WO2006045564A1
(en)
|
2004-10-22 |
2006-05-04 |
Smithkline Beecham Corporation |
Xanthine derivatives with hm74a receptor activity
|
JP2008517029A
(ja)
|
2004-10-22 |
2008-05-22 |
スミスクライン・ビーチャム・コーポレイション |
Hm74a受容体活性を有するキサンチン誘導体
|
WO2006059744A1
(ja)
|
2004-11-30 |
2006-06-08 |
Nippon Chemiphar Co., Ltd. |
ペルオキシソーム増殖剤活性化受容体δの活性化剤
|
BRPI0519566A2
(pt)
|
2004-12-18 |
2009-01-27 |
Bayer Healthcare Ag |
derivados de (5s)-3-[(s)-fléor(4-trifluormetilfenil)metil]-5,6,7,8-tet raidroquinolin-5-ol e seu uso como inibidores de cetp
|
PE20060949A1
(es)
|
2004-12-23 |
2006-10-11 |
Arena Pharm Inc |
Derivados fusionados de pirazol como agonistas del receptor de niacina
|
JP4980928B2
(ja)
|
2004-12-24 |
2012-07-18 |
プロシディオン・リミテッド |
Gタンパク質共役受容体(gpr116)作動薬および肥満および糖尿病治療のためのその使用
|
WO2006067532A1
(en)
|
2004-12-24 |
2006-06-29 |
Prosidion Ltd |
G-protein coupled receptor agonists
|
KR101238525B1
(ko)
|
2004-12-31 |
2013-02-28 |
레디 유에스 테라퓨틱스 인코포레이티드 |
Cetp 저해제로서의 신규 벤질아민 유도체
|
DE102005000666B3
(de)
|
2005-01-04 |
2006-10-05 |
Sanofi-Aventis Deutschland Gmbh |
Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
JP2008528700A
(ja)
|
2005-02-03 |
2008-07-31 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Pparモジュレーターとしての化合物および組成物
|
EP1851197A2
(en)
|
2005-02-09 |
2007-11-07 |
Microbia, Inc. |
Phenylazetidinone derivatives
|
FR2883000B1
(fr)
|
2005-03-14 |
2007-06-01 |
Merck Sante Soc Par Actions Si |
Derives de trifluoromethylbenzamide et leurs utilisations en therapeutique
|
WO2006102674A2
(en)
|
2005-03-24 |
2006-09-28 |
Microbia, Inc. |
Diphenylheterocycle cholesterol absorption inhibitors
|
WO2006113150A1
(en)
|
2005-04-13 |
2006-10-26 |
Merck & Co., Inc. |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
US20080194494A1
(en)
|
2005-04-26 |
2008-08-14 |
Microbia, Inc. |
4-Biarylyl-1-Phenylazetidin-2-One Glucuronide Derivatives for Hypercholesterolemia
|
WO2006121861A2
(en)
|
2005-05-05 |
2006-11-16 |
Microbia, Inc. |
Biphenylazetidinone cholesterol absorption inhibitors
|
JP2008539735A
(ja)
|
2005-05-06 |
2008-11-20 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
グルカゴン様ペプチド1(glp−1)受容体アンタゴニストおよびそれらの薬理学的使用方法
|
WO2006122186A2
(en)
|
2005-05-10 |
2006-11-16 |
Microbia, Inc. |
1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia
|
EA200702464A1
(ru)
|
2005-05-11 |
2008-04-28 |
Майкробиа, Инк. |
Способы получения фенольных 4-бифенилилазетидин-2-онов
|
PT1881850E
(pt)
|
2005-05-13 |
2010-11-26 |
Lilly Co Eli |
Compostos peguilados de glp-1
|
AU2006247695B2
(en)
|
2005-05-17 |
2012-08-09 |
Merck Sharp & Dohme Corp. |
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
|
AU2006249905A1
(en)
|
2005-05-25 |
2006-11-30 |
Microbia, Inc. |
Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
|
EP1893222A4
(en)
|
2005-06-15 |
2010-07-07 |
Merck Sharp & Dohme |
ANTI-HYPERCHOLESTEROLEMIC COMPOUNDS
|
UY29607A1
(es)
|
2005-06-20 |
2007-01-31 |
Astrazeneca Ab |
Compuestos quimicos
|
AR054482A1
(es)
|
2005-06-22 |
2007-06-27 |
Astrazeneca Ab |
Derivados de azetidinona para el tratamiento de hiperlipidemias
|
MY148538A
(en)
|
2005-06-22 |
2013-04-30 |
Astrazeneca Ab |
Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
|
SA06270191B1
(ar)
|
2005-06-22 |
2010-03-29 |
استرازينيكا ايه بي |
مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
|
AR056866A1
(es)
|
2005-06-22 |
2007-10-31 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, una formulacion farmaceutica y un proceso de preparacion del compuesto
|
AR057380A1
(es)
|
2005-06-22 |
2007-11-28 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
|
AR057383A1
(es)
|
2005-06-22 |
2007-12-05 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
|
US7067689B1
(en)
*
|
2005-07-08 |
2006-06-27 |
Microbia, Inc. |
Process for production of pentahydroxyhexylcarbamoyl alkanoic acids
|
JP2007022943A
(ja)
|
2005-07-13 |
2007-02-01 |
Dai Ichi Seiyaku Co Ltd |
スクアレン合成酵素阻害薬
|
DE102005033099A1
(de)
|
2005-07-15 |
2007-01-18 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindung enthaltende Arzneimittel und dessen Verwendung
|
DE102005033100B3
(de)
|
2005-07-15 |
2007-01-25 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, diese Verbindung enthaltene Arzneimittel und Verfahren zu deren Herstellung
|
WO2007015744A1
(en)
|
2005-07-21 |
2007-02-08 |
Incyte Corporation |
Disubstituted thienyl compounds and their use as pharmaceuticals
|
GB0516462D0
(en)
|
2005-08-10 |
2005-09-14 |
Smithkline Beecham Corp |
Novel compounds
|
PT1912991E
(pt)
|
2005-08-10 |
2011-01-17 |
Glaxosmithkline Llc |
Derivados de xantina como agonistas selectivos de hm74a
|
WO2007027532A2
(en)
|
2005-08-29 |
2007-03-08 |
Merck & Co., Inc. |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
CA2621227A1
(en)
|
2005-08-31 |
2007-03-08 |
Astellas Pharma Inc. |
Thiazole derivative
|
BRPI0616465A2
(pt)
|
2005-09-29 |
2011-06-21 |
Sanofi Aventis |
derivados de fenil-[1,2,4]-oxadiazol-5-ona com grupo fenila, bem como seu uso, composição farmacêutica compreendo os mesmos e processo de preparação da referida composição farmacêutica
|
US20100167986A1
(en)
|
2005-09-30 |
2010-07-01 |
Amjad Ali |
Cholesteryl Ester Transfer Protein Inhibitors
|
DE102005055726A1
(de)
*
|
2005-11-23 |
2007-08-30 |
Sanofi-Aventis Deutschland Gmbh |
Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
US20080319221A1
(en)
|
2007-06-22 |
2008-12-25 |
Bernd Junker |
Esters of Pentahydroxyhexylcarbamoyl Alkanoic Acids
|
US20080319218A1
(en)
*
|
2007-06-22 |
2008-12-25 |
Andreas Haubrich |
Processes for Making and Using Benzyl Pentahydroxyhexylcarbamoylundecanoate
|
WO2009112203A1
(de)
*
|
2008-03-14 |
2009-09-17 |
Sanofi-Aventis Deutschland Gmbh |
Verfahren zur herstellung eines diphenylazetidinons
|